Phospholipase C-β in immune cells

Advances in Biological Regulation

Volumn 53, Issue 3, 2013, Pages 249-257

  Kawakami, Toshiaki ^a,b   Xiao, Wenbin ^c  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Institute of Physical and Chemical Research   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTOKINE; DIACYLGLYCEROL; G PROTEIN COUPLED RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; ISOENZYME; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA; PROSTAGLANDIN; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR; TITANIUM;

ANIMAL; BCR; BONE MARROW CELL; C-TERMINAL; CT; CYTOLOGY; DAG; DKO; DOUBLE KNOCKOUT; ENZYMOLOGY; G-PROTEIN-COUPLED RECEPTOR; GAP; GENETICS; GTPASE-ACTIVATING PROTEIN; HEMATOPOIETIC STEM CELL; HSC; HUMAN; HYDROXYLNITROPHENYL; IL; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; IP(3); ITAM; LYMPHOCYTE; NP; PG; PKC; PLC; REVIEW; SH2; SRC HOMOLOGY 2; T CELL-INDEPENDENT; TCR; TNFΑ; TUMOR NECROSIS FACTOR Α;

B CELL RECEPTOR; BCR; C-TERMINAL; CT; DAG; DIACYLGLYCEROL; DKO; DOUBLE KNOCKOUT; G-PROTEIN-COUPLED RECEPTOR; GAP; GPCR; GTPASE-ACTIVATING PROTEIN; HEMATOPOIETIC STEM CELL; HSC; HYDROXYLNITROPHENYL; IL; IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF; INOSITOL 1,4,5-TRISPHOSPHATE; INTERLEUKIN; IP(3); ITAM; NP; PG; PHOSPHOLIPASE C; PKC; PLC; PROSTAGLANDIN; PROTEIN KINASE C; SH2; SRC HOMOLOGY 2; T CELL RECEPTOR; T CELL-INDEPENDENT; TCR; TI; TNFΑ; TUMOR NECROSIS FACTOR Α;

ANIMALS; HUMANS; IMMUNE SYSTEM; ISOENZYMES; LYMPHOCYTES; MYELOID CELLS; PHOSPHOLIPASE C BETA;

EID: 84885763427     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2013.08.001     Document Type: Review

References (69)

1. Abraham R.T., Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nature Reviews Immunology 2004, 4:301-308.
2. Abraham S.N., St John A.L. Mast cell-orchestrated immunity to pathogens. Nature Reviews Immunology 2010, 10:440-452.
3. Abu-Dayyeh I., Ralph B., Grayfer L., Belosevic M., Cousineau B., Oliver M. Identification of key cytosolic kinases containing evolutionarily conserved kinase tyrosine-based inhibitory motifs (KTIMs). Developmental and Comparative Immunology 2010, 34:481-484.
4. Abu-Dayyeh I., Shio M.T., Sato S., Akira S., Cousineau B., Olivier M. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Neglected Tropical Diseases 2008, 2:e305.
5. Adjobo-Hermans M.J., Crosby K.C., Putyrski M., Bhageloe A., van Weeren L., Schultz C., et al. PLCbeta isoforms differ in their subcellular location and their CT-domain dependent interaction with Galphaq. Cellular Signalling 2013, 25:255-263.
6. Allen C.D., Ansel K.M., Low C., Lesley R., Tamamura H., Fujii N., et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nature Immunology 2004, 5:943-952.
7. Bach T.L., Chen Q.M., Kerr W.T., Wang Y., Lian L., Choi J.K., et al. Phospholipase cbeta is critical for T cell chemotaxis. Journal of Immunology 2007, 179:2223-2227.
8. Benhamou M., Ryba N.J., Kihara H., Nishikata H., Siraganian R.P. Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling. Identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation. The Journal of Biological Chemistry 1993, 268:23318-23324.
9. Bueno C., Lemke C.D., Criado G., Baroja M.L., Ferguson S.S., Rahman A.K., et al. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity 2006, 25:67-78.
10. Bunney T.D., Harris R., Gandarillas N.L., Josephs M.B., Roe S.M., Sorli S.C., et al. Structural and mechanistic insights into ras association domains of phospholipase C epsilon. Molecular Cell 2006, 21:495-507.
11. Bunney T.D., Katan M. PLC regulation: emerging pictures for molecular mechanisms. Trends in Biochemical Sciences 2011, 36:88-96.
12. Calo L.A., Bordin L., Davis P.A., Pagnin E., Dal Maso L., Rossi G.P., et al. PLCbeta1-SHP-2 complex, PLCbeta1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?. Journal of Biomedical Science 2011, 18:38.
13. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annual Review of Immunology 2005, 23:127-159.
14. Di Pietro R., Miscia S., Cataldi A., Rana R. Age-dependent variations in the expression of PLC isoforms upon mitogenic stimulation of peripheral blood T cells from healthy donors. British Journal of Haematology 2000, 111:1209-1214.
15. Di Pietro R., Rana R. Age-related defect of phospholipase C activity, differential expression of the beta 2 isoform in active T lymphocytes from aged humans. Human Immunology 1998, 59:25-28.
16. Eiseman E., Bolen J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992, 355:78-80.
17. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996, 87:1037-1047.
18. Galli S.J., Tsai M. IgE and mast cells in allergic disease. Nature Medicine 2012, 18:693-704.
19. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
20. Gresset A., Sondek J., Harden T.K. The phospholipase C isozymes and their regulation. Subcellular Biochemistry 2012, 58:61-94.
21. Grinberg S., Hasko G., Wu D., Leibovich S.J. Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype. The American Journal of Pathology 2009, 175:2439-2453.
22. Harden T.K., Hicks S.N., Sondek J. Phospholipase C isozymes as effectors of Ras superfamily GTPases. Journal of Lipid Research 2009, 50(Suppl.):S243-S248.
23. Harden T.K., Sondek J. Regulation of phospholipase C isozymes by ras superfamily GTPases. Annual Review of Pharmacology and Toxicology 2006, 46:355-379.
24. Hauk P.J., Hamid Q.A., Chrousos G.P., Leung D.Y. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. The Journal of Allergy and Clinical Immunology 2000, 105:782-787.
25. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
26. Inagaki N., Goto S., Yamasaki M., Nagai H., Koda A. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. International Archives of Allergy and Applied Immunology 1986, 80:285-290.
27. Jiang H., Kuang Y., Wu Y., Xie W., Simon M.I., Wu D. Roles of phospholipase C beta2 in chemoattractant-elicited responses. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:7971-7975.
28. Jouvin M.H., Adamczewski M., Numerof R., Letourneur O., Valle A., Kinet J.P. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. The Journal of Biological Chemistry 1994, 269:5918-5925.
29. Kadamur G., Ross E.M. Mammalian phospholipase C. Annual Review of Physiology 2013, 75:127-154.
30. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nature Immunology 2008, 9:1215-1223.
31. Kawakami T., Xiao W., Yasudo H., Kawakami Y. Regulation of proliferation, survival, differentiation, and activation by the Signaling Platform for SHP-1 phosphatase. Advances in Biological Regulation 2012, 52:7-15.
32. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annual Review of Immunology 1999, 17:931-972.
33. Klein R.R., Bourdon D.M., Costales C.L., Wagner C.D., White W.L., Williams J.D., et al. Direct activation of human phospholipase C by its well known inhibitor u73122. The Journal of Biological Chemistry 2011, 286:12407-12416.
34. Kremer K.N., Clift I.C., Miamen A.G., Bamidele A.O., Qian N.X., Humphreys T.D., et al. Stromal cell-derived factor-1 signaling via the CXCR4-TCR heterodimer requires phospholipase C-beta3 and phospholipase C-gamma1 for distinct cellular responses. Journal of Immunology 2011, 187:1440-1447.
35. Kremer K.N., Humphreys T.D., Kumar A., Qian N.X., Hedin K.E. Distinct role of ZAP-70 and Src homology 2 domain-containing leukocyte protein of 76 kDa in the prolonged activation of extracellular signal-regulated protein kinase by the stromal cell-derived factor-1 alpha/CXCL12 chemokine. Journal of Immunology 2003, 171:360-367.
36. Kuehn H.S., Beaven M.A., Ma H.T., Kim M.S., Metcalfe D.D., Gilfillan A.M. Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release. Cellular Signalling 2008, 20:625-636.
37. Kuehn H.S., Gilfillan A.M. G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation. Immunology Letters 2007, 113:59-69.
38. Kumar A., Humphreys T.D., Kremer K.N., Bramati P.S., Bradfield L., Edgar C.E., et al. CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 2006, 25:213-224.
39. Laffargue M., Calvez R., Finan P., Trifilieff A., Barbier M., Altruda F., et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 2002, 16:441-451.
40. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., Wu D. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 2000, 287:1046-1049.
41. Lowenberg M., Tuynman J., Bilderbeek J., Gaber T., Buttgereit F., van Deventer S., et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 2005, 106:1703-1710.
42. Lowenberg M., Verhaar A.P., Bilderbeek J., Marle J., Buttgereit F., Peppelenbosch M.P., et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Reports 2006, 7:1023-1029.
43. Lyon A.M., Dutta S., Boguth C.A., Skiniotis G., Tesmer J.J. Full-length Galpha(q)-phospholipase C-beta3 structure reveals interfaces of the C-terminal coiled-coil domain. Nature Structural & Molecular Biology 2013, 20:355-362.
44. Lyon A.M., Tesmer V.M., Dhamsania V.D., Thal D.M., Gutierrez J., Chowdhury S., et al. An autoinhibitory helix in the C-terminal region of phospholipase C-beta mediates Galphaq activation. Nature Structural & Molecular Biology 2011, 18:999-1005.
45. Mandal M., Powers S.E., Maienschein-Cline M., Bartom E.T., Hamel K.M., Kee B.L., et al. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nature Immunology 2011, 12:1212-1220.
46. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526-530.
47. Metzger H. The receptor with high affinity for IgE. Immunological Reviews 1992, 125:37-48.
48. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145:341-355.
49. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
50. Okada Y., Kamatani Y., Takahashi A., Matsuda K., Hosono N., Ohmiya H., et al. Common variations in PSMD3-CSF3 and PLCB4 are associated with neutrophil count. Human Molecular Genetics 2010, 19:2079-2085.
51. Pollard J.W. Trophic macrophages in development and disease. Nature Reviews Immunology 2009, 9:259-270.
52. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annual Review of Biochemistry 2001, 70:281-312.
53. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annual Review of Immunology 2004, 22:891-928.
54. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. Embo Journal 1998, 17:1961-1972.
55. Seehaus S., Shahzad K., Kashif M., Vinnikov I.A., Schiller M., Wang H., et al. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability. Circulation 2009, 120:774-784.
56. Shirakawa A.K., Liao F., Zhang H.H., Hedrick M.N., Singh S.P., Wu D., et al. Pathway-selective suppression of chemokine receptor signaling in B cells by LPS through downregulation of PLC-beta2. Cellular & Molecular Immunology 2010, 7:428-439.
57. Smit M.J., Verdijk P., van der Raaij-Helmer E.M., Navis M., Hensbergen P.J., Leurs R., et al. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 2003, 102:1959-1965.
58. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annual Review of Immunology 2009, 27:591-619.
59. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. Biochemistry and Molecular Biology Reports 2008, 41:415-434.
60. Verhaar A.P., Wildenberg M.E., Duijvestein M., Vos A.C., Peppelenbosch M.P., Lowenberg M., et al. Superantigen-induced steroid resistance depends on activation of phospholipase cbeta2. Journal of Immunology 2013, 190:6589-6595.
61. Waldo G.L., Ricks T.K., Hicks S.N., Cheever M.L., Kawano T., Tsuboi K., et al. Kinetic scaffolding mediated by a phospholipase C-beta and Gq signaling complex. Science 2010, 330:974-980.
62. Wang Z., Liu B., Wang P., Dong X., Fernandez-Hernando C., Li Z., et al. Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. The Journal of Clinical Investigation 2008, 118:195-204.
63. Wershil B.K., Wang Z.S., Gordon J.R., Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. Journal of Clinical Investigation 1991, 87:446-453.
64. Xiao W., Ando T., Wang H.Y., Kawakami Y., Kawakami T. Lyn- and PLC-beta3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease. Blood 2010, 116:6003-6013.
65. Xiao W., Hong H., Kawakami Y., Kato Y., Wu D., Yasudo H., et al. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell. 2009, 16:161-171.
66. Xiao W., Kashiwakura J., Hong H., Yasudo H., Ando T., Maeda-Yamamoto M., et al. Phospholipase c-beta3 regulates FcvarepsilonRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1. Immunity 2011, 34:893-904.
67. Xiao W., Nishimoto H., Hong H., Kitaura J., Nunomura S., Maeda-Yamamoto M., et al. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. Journal of Immunology 2005, 175:6885-6892.
68. Yablonski D., Kuhne M.R., Kadlecek T., Weiss A. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 1998, 281:413-416.
69. Yasudo H., Ando T., Xiao W., Kawakami Y., Kawakami T. Short Stat5-interacting peptide derived from phospholipase C-beta3 inhibits hematopoietic cell proliferation and myeloid differentiation. PloS One 2011, 6:e24995.